The Discounted Cash Flow (DCF) valuation of Arrowhead Pharmaceuticals Inc (ARWR) is (126.56) USD. With the latest stock price at 21.85 USD, the upside of Arrowhead Pharmaceuticals Inc based on DCF is -679.2%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.9% - 8.8% | 7.8% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (239.70) - (88.55) | (126.56) |
| Upside | -1197.0% - -505.2% | -679.2% |